GeoWealth Management LLC Sells 2,320 Shares of Invesco Biotechnology & Genome ETF (NYSEARCA:PBE)

GeoWealth Management LLC decreased its stake in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) by 18.5% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 10,246 shares of the company’s stock after selling 2,320 shares during the quarter. GeoWealth Management LLC’s holdings in Invesco Biotechnology & Genome ETF were worth $682,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. JPMorgan Chase & Co. increased its stake in Invesco Biotechnology & Genome ETF by 30.0% in the fourth quarter. JPMorgan Chase & Co. now owns 650 shares of the company’s stock valued at $43,000 after acquiring an additional 150 shares during the last quarter. Millstone Evans Group LLC purchased a new position in shares of Invesco Biotechnology & Genome ETF in the 4th quarter worth about $64,000. Jones Financial Companies Lllp increased its position in shares of Invesco Biotechnology & Genome ETF by 52.9% during the 4th quarter. Jones Financial Companies Lllp now owns 2,315 shares of the company’s stock valued at $154,000 after purchasing an additional 801 shares during the last quarter. Farther Finance Advisors LLC purchased a new position in shares of Invesco Biotechnology & Genome ETF during the 4th quarter valued at about $161,000. Finally, Jane Street Group LLC bought a new stake in Invesco Biotechnology & Genome ETF in the 3rd quarter worth approximately $295,000.

Invesco Biotechnology & Genome ETF Price Performance

Shares of NYSEARCA PBE opened at $59.03 on Monday. The stock has a market capitalization of $212.51 million, a P/E ratio of 21.05 and a beta of 0.83. Invesco Biotechnology & Genome ETF has a one year low of $54.52 and a one year high of $72.84. The firm’s 50 day simple moving average is $64.03 and its two-hundred day simple moving average is $67.12.

About Invesco Biotechnology & Genome ETF

PowerShares Dynamic Biotechnology & Genome Portfolio (the Fund) is based on the Dynamic Biotechnology & Genome Intellidex Index (the Index). The Fund seeks investment results that correspond generally to the price and yield of the Index. The Index consists of stocks of 30 the United States biotechnology and genome companies.